Soluble biomarkers to predict clinical outcomes in non-small cell lung cancer treated by immune checkpoints inhibitors

Lung cancer remains the first cause of cancer-related death despite many therapeutic innovations, including immune checkpoint inhibitors (ICI). ICI are now well used in daily practice at late metastatic stages and locally advanced stages after a chemo-radiation. ICI are also emerging in the peri-ope...

Descripción completa

Detalles Bibliográficos
Autores principales: Ancel, Julien, Dormoy, Valérian, Raby, Béatrice Nawrocki, Dalstein, Véronique, Durlach, Anne, Dewolf, Maxime, Gilles, Christine, Polette, Myriam, Deslée, Gaëtan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239865/
https://www.ncbi.nlm.nih.gov/pubmed/37283751
http://dx.doi.org/10.3389/fimmu.2023.1171649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239865/
https://www.ncbi.nlm.nih.gov/pubmed/37283751
http://dx.doi.org/10.3389/fimmu.2023.1171649

Ejemplares similares